Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Is a |
Product containing prednisolone (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Is a |
Product containing sulfacetamide (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Is a |
Prednisolone-containing product in ocular dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Is a |
Ophthalmic sulfonamide preparation |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sulfacetamide (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Prednisolone ophthalmic preparation |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sulfonamide (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sulfacetamide sodium |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Prednisolone acetate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Is a |
Prednisolone acetate + sulfacetamide sodium |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bactericide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Glucocorticoid hormone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has manufactured dose form |
Ocular dose form (dose form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Is a |
Product containing sulfacetamide in ophthalmic dosage form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has manufactured dose form |
Eye ointment (product) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Is a |
TEMPORARY parent for CDs that are not updated |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has concentration strength numerator unit |
mcg |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has concentration strength denominator unit (attribute) |
mg |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Count of base of active ingredient |
deux |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Is a |
Prednisolone and sulfacetamide only product in ocular dose form |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has concentration strength denominator unit (attribute) |
mg |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has concentration strength numerator unit |
mcg |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has concentration strength numerator value |
2.5 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has basis of strength substance (attribute) |
Prednisolone acetate |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has basis of strength substance (attribute) |
Sulfacetamide sodium |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has precise active ingredient |
Prednisolone acetate |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has precise active ingredient |
Sulfacetamide sodium |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has concentration strength numerator value |
10^2 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Plays role |
Antibacterial therapeutic role (role) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has concentration strength numerator unit |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has concentration strength denominator unit (attribute) |
g |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has concentration strength numerator unit |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Prednisolone acetate 2.5 mg/g and sulfacetamide sodium 100 mg/g eye ointment |
Has concentration strength denominator unit (attribute) |
g |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|